title: [Monitoring of methotrexate treatment of children with proliferative diseases of the hematopoietic system].
authors.forename: J
authors.initials: J
authors.lastname: Bogusławska-Jaworska
authors.forename: K
authors.initials: K
authors.lastname: Orzechowska-Juzwenko
authors.forename: J
authors.initials: J
authors.lastname: Pejcz
authors.forename: A
authors.initials: A
authors.lastname: Wiela-Hojeńska
authors.forename: M
authors.initials: M
authors.lastname: Szczepaniak
authors.forename: J
authors.initials: J
authors.lastname: Erbel-Badeńska
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D008223:Lymphoma / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage* / Q000633:toxicity; D008991:Monitoring, Physiologic; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
chemical_list: D008727:Methotrexate
vernacular_title: Nadzorowanie leczenia metotreksatem u dzieci z chorobami rozrostowymi układu krwiotwórczego.